Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05197920 · ClinicalTrials.gov registry record
Diabetes RElated to Acute Pancreatitis and Its Mechanisms
A clinical trial of Acute Pancreatitis, sponsored by Milton S. Hershey Medical Center.
- Recruiting
- Registry status
- 800
- Enrollment target
- 13
- Study locations
NCT05197920 is a study of Acute Pancreatitis that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 800 participants, below the 2,239-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (64% lower). The trial reports 13 study locations across 9 states.
The verdict
NCT05197920, a study of Acute Pancreatitis, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 13
- Study locations
Study Summary
The overriding objective of DREAM is to conduct a prospective longitudinal (36 months) observational clinical study to investigate the incidence, etiology, and pathophysiology of diabetes mellitus (DM) following acute pancreatitis (AP).
Conditions Studied
Study Locations (13)
California
- University of Southern California - Los Angeles
- Cedars-Sinai Medical Center - Los Angeles
- Stanford University - Stanford
Florida
- University of Florida - Gainesville
- AdventHealth - Orlando
Illinois
- Northwestern University - Chicago
- University of Illinois at Chicago - Chicago
Indiana
- Indiana University - Indianapolis
Maryland
- Johns Hopkins University - Baltimore
Minnesota
- University of Minnesota - Minneapolis
Ohio
- Ohio State University - Columbus
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2022-01-14 |
| Est. Completion | 2030-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05197920
The ClinicalTrials.gov registry entry for NCT05197920 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 800 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,239-participant average among 10 other Acute Pancreatitis trials with a reported enrollment target (64% lower). The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Pancreatitis appearing as the primary indexed condition, and to 0 interventions.
NCT05197920 reports 13 study locations spanning 9 distinct geographic areas - top geographies include California, Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT05197920 about?
NCT05197920 is a clinical study titled "Diabetes RElated to Acute Pancreatitis and Its Mechanisms". The overriding objective of DREAM is to conduct a prospective longitudinal (36 months) observational clinical study to investigate the incidence, etiology, and pathophysiology of diabetes mellitus (DM) following acute pancreatitis (AP).
What is the current status of trial NCT05197920?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2022-01-14. Estimated completion is 2030-01-31.
What conditions does trial NCT05197920 study?
This clinical trial studies the following conditions: Acute Pancreatitis.
Who is sponsoring clinical trial NCT05197920?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05197920 being conducted?
This trial has 13 study locations across California, Florida, Illinois, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Pancreatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis
RECRUITING
-
iMmune SignAtures and Clinical outComes in AP
RECRUITING
-
Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections
RECRUITING
-
Necrosectomy With Cryotechnology for Accelerated Removal
RECRUITING · NA
-
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RECRUITING
-
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.